SCHEMBL7005111

SCHEMBL7005111

COc1ccc(N)cc1OCCN1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 5/20 0.48
DRD2 P14416 1/20 0.47
NR1H2 P55055 1/20 0.46
RXFP1 Q9HBX9 1/20 0.45
NSD2 O96028 1/20 0.44
EHMT2 Q96KQ7 1/20 0.44
CFTR P13569 1/20 0.44
ALDH1A1 P00352 1/20 0.44
EPHX2 P34913 3/20 0.44
PDE4B Q07343 2/20 0.43
HTR4 Q13639 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
GPR4 P46093 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4C Q08493 1/20 0.42
PDE4D Q08499 1/20 0.42
CD274 Q9NZQ7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1667304 0.95 NSD2 (0.49) DRD3NR1H2NSD2EHMT2CFTR
SCHEMBL22118030 0.87 HTR1B (0.52) NR1H2RXFP1ALDH1A1EPHX2GPR4
SCHEMBL22118023 0.85 RXFP1 (0.48) NR1H2RXFP1ALDH1A1EPHX2GPR4
SCHEMBL7011905 0.83 ALDH1A1 (0.53) DRD3DRD2RXFP1ALDH1A1
SCHEMBL1669652 0.83 GPR119 (0.55) PDE4BPDE4APDE4CPDE4D
SCHEMBL18910793 0.82 EPHX2 (0.48) NR1H2NSD2EHMT2ALDH1A1EPHX2
SCHEMBL14453658 0.82 DRD3 (0.54) DRD3DRD2ALDH1A1EPHX2GPR4
SCHEMBL28343487 0.81 AXL (0.51)
SCHEMBL7003036 0.80 RXFP1 (0.44) DRD3DRD2RXFP1NSD2EHMT2
SCHEMBL18910796 0.80 EPHX2 (0.47) NR1H2RXFP1NSD2EHMT2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1309551-A1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 2003-05-14 EP disclosed
WO-2002014273-A1 INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS SMITHKLINE BEECHAM P.L.C. (GB) 2002-02-21 WO disclosed